Skip to main content
Clinical Trials/NL-OMON20548
NL-OMON20548
Completed
N/A

The contribution of genetic predisposition to pediatric cancer: a study integrating extensive phenotyping and state of the art genotyping

Princes Máxima Center for pediatric oncology0 sites843 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
<p>Pediatric cancer/neoplasms</p>
Sponsor
Princes Máxima Center for pediatric oncology
Enrollment
843
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Princes Máxima Center for pediatric oncology

Eligibility Criteria

Inclusion Criteria

  • \- Children (age \< 19 years) newly diagnosed with cancer or neoplasms at the Princess Máxima Center \- Written informed consent (by patient when aged 16 years or older, by patient and parent(s) when aged 12\-16 years, by parent(s) when younger than 12 years)

Exclusion Criteria

  • \- Patients and/or their parents who don't want to know the results of the DNA test (pediatric cancer gene panel analysis)

Outcomes

Primary Outcomes

Not specified

Similar Trials